The marked affinity of erythrocytes for hexavalent chromate anion was reported in 1950 by Gray and Sterling (1) . Since then, erythrocytes labeled with radioactive sodium chromate have been used extensively for the determination of erythrocyte survival in vivo (1) (2) (3) (4) (5) and the determination of blood volume (4) (5) (6) . The anionic hexavalent form of chromium is bound firmly to erythrocytes, is not reutilized, and is excreted mainly in the urine (2) . Gray and Sterling suggested that the hexavalent form of chromium in the erythrocyte is probably bound to hemoglobin. Recent work, however, has shown that not all of the chromium is attached to hemoglobin, but that some of it is combined with a substance of low molecular weight, possibly glutathione (7).
Ebaugh, Emerson, and Ross (2) showed that small amounts of chromate, up to 9.5 Fg of chromium per ml of blood, had no apparent effect on the survival of erythrocytes in vivo. When 35 pg per ml of blood was used, however, there was significant hemolysis in vivo during the first 24 hours. Donohue and associates (5) found that amounts below 25 ug of chromium per ml of erythrocytes did not affect erythrocyte survival, but that larger amounts were toxic. In this paper we report the results of studies of the effect of chromate on erythrocyte enzymes. A marked inhibition of glutathione-reductase (GSSG-R) activity was observed. Upon incubation with acetylphenylhydrazine, chromatetreated erythrocytes had an increased tendency to form Heinz bodies, and there was some decrease in glutathione stability.
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Methods
Materials. Human blood was obtained from healthy volunteers or patients with no hematologic abnormalities. Polyvinylpyrrolidone, Plasdone C (PVP) 1; disodium EDTA, 3 times recrystallized 2; Tris (Sigma 121), ADP, ATP, 6-phosphogluconate, ribose-5-phosphate, GSSG, and aldolase 3; adenosine, glycylglycine, nicotinamide, and acetylcholine chloride 4; DPNH, TPN, TPNH, fructose-6-phosphate, DL-glyceraldehyde-3-phosphate, 3-phosphoglycerate, 2-phosphoglycerate, glucose-6-phosphate, GSH, glucose-6-phosphate dehydrogenase (G-6-P-D), a-glycerophosphate dehydrogenase, phosphoglycerate kinase, pyruvate kinase, lactic dehydrogenase, and triose phosphate isomerase 5; fructose-1,6-diphosphate, phosphoenolpyruvate and enolase 6; sodium chromate (NaCrO,*4H2O), chromium chloride (CrCl, -6HO), and triethanolamine (TEA)7; ascorbic acid 8; hydrazine sulfate, iodoacetic acid, 2,4-dinitrophenylhydrazine, and acetylphenylhydrazine 9; pyruvic acid 10; 5,5'-dithiobis(2-nitrobenzoic acid) 11; and ACD solution, Abbott special formula (132 mg dextrose, 250 mg sodium citrate, 80 mg citric acid, and HO QS to 10 ml)12 were obtained commercially. Deionized distilled water was used throughout all of the experiments.
Methods. Incubation of erythrocytes with chromium was carried out as described by Wintrobe (8) for cell labeling with modifications as follows: 4 vol of fresh blood was added to 1 vol of ACD solution. The supernatant ACD-plasma was discarded after centrifugation for 10 minutes at 500 X g at 40 C in an International model PR-2 refrigerated centrifuge. To the packed erythrocytes, sodium chromate was added in amounts varying from 1.0 to 100 sAg of elemental chromium per ml of original blood volume. The concentrations of chromate used throughout this paper are expressed as micrograms of elemental chromium per milliliter of original blood and not in terms of erythrocyte volume. The mixture was incubated in a water bath at 370 C for 45 minutes with frequent mixing. At the end of incubation ascorbic acid, 5 mg per ml of initial blood volume, was added. The erythrocytes were washed 3 times with cold isotonic saline and were resuspended in isotonic saline to a concentration of approximately 3,000,000 erythrocytes per 11. The erythrocytes were enumerated with the Coulter counter, model A. This erythrocyte-rich suspension was utilized for the various enzyme determinations. Except when otherwise noted, hemolysates prepared by lysis in distilled water followed by freezing and thawing were used for the determination of enzyme activities. Spectrophotometric assays were performed in a 3-ml reaction volume in a silica cell of 1-cm light path in a Beckman DU spectrophotometer 13 coupled with a multiple sample absorbance recorder 14 at 370 C. All spectrophotometric assays other than the glyoxalase determination were performed at 340 mpa, and a molar extinction coefficient of 6.22 X 103 for DPNH and TPNH was employed in the calculations (9) . Colorimetric determinations were performed in a Beckman model B spectrophotometer. 13 Hexokinase was determined spectrophotometrically in a reaction mixture containing glycylglycine buffer, pH 8.1 (25 ,umoles) cytes, prepared by mixing 1 part erythrocyte-rich suspension, 2 parts TEA buffer, and 6 parts normal saline, followed by freezing and thawing. After 30 minutes' incubation, triose production was measured in a trichloroacetic acid fiitrate.
Triose phosphate isomerase was assayed by a modification of the spectrophotometric method of Beisenherz (11) . The reaction mixture contained TEA buffer, pH 7.6 (130 Amoles), DPNH (0.5 /Amoles), DL-glyceraldehyde-3-phosphate (0.9 ;Lmoles), c-glycerophosphate dehydrogenase (3.5 to 5.0 EU), and hemolysate equivalent to 1.0 X 106 erythrocytes.
Glyceraldehyde-3-phosphate dehydrogenase was assayed spectrophotometrically as described by Beisenherz and co-workers (12), adapted for hemolysate. The mixture contained TEA buffer, pH 7.6 (125 umoles), 3-phosphoglycerate (12 /Amoles), ATP (3.2 /4moles), EDTA, pH 7.6 (0.5 mg), MgSO, (24 /imoles), DPNH (0.75 ,umoles), phosphoglycerate kinase (5 EU), and hemolysate equivalent to 6.0 X 106 erythrocytes.
Phosphoglycerate kiniase activity was determined in a linked system utilizing pyruvate kinase. The method depends upon the conversion of ATP to ADP. The ADP thus generated is quantitated as limiting factor in the pyruvate kinase reaction. This method was developed in our laboratory to avoid interference by the large quantities of 2,3-diphosphoglycerate present in human erythrocytes and has proved very satisfactory. The system contained TEA buffer, pH 7.6 (50 iumoles), MgSO, (24 ,umoles) (21) . The other columns represent enzyme activities of erythrocyte suspensions incubated with chromate as described in the text. The assay values of the chromated erythrocytes represent the mean of five samples of normal blood with the exception of the glyoxalase assays, which represent the mean of three samples.
thiamine pyrophosphate, phosphoribose isomerase, and phosphoketopentose epimerase, as well as of transketolase. The latter enzyme was the limiting factor in the reaction. Pyruvate kinase, enlolase, lactic dehydrogenase, G-6-P-D, 6-phosphogluconic dehydrogenase, and acetylcholinesterase were performed as previously reported (14) . Glutathione reductase was measured as described by Long and Carson (15) uti:izing stroma-containing hemolysate. Glyoxalase activity was assayed as previously reported (16) .
After preincubation of erythrocytes with sodium chromate as described above, the washed erythrocytes were resuspended in various media for the following studies: Glutathione stability was determined on erythrocytes resuspended in heparinized plasma and in some experiments in 0.12 M phosphate buffer, pH 7.5, containing glucose (2 mg per ml). The procedure was performed essentially as described by Beutler (17) . GSH was measured by a -slight modification of the 5,5'-dithiobis (2-nitrobenzoic acid) method of Beutler, Duron, and Kelly (18) . Autohemolysis was determined as previously described (14) after reconstitution of the chromated erythrocytes in defibrinated serum. Erythrocyte osmotic fragility as described by Dacie (19) Table I . In general no major deviations from normal were noted. When GSSG-R was assayed, however, there was a significant reduction in its activity. Progressive reduction of GSSG-R activity was noted with increasing concentrations of chromate Although ascorbic acid was utilized as a simple reducing agent, it might have influenced the GSSG-R inhibition in a more active fashion, possibly through stimulation of the pentose phosphate pathway. No significant differences in inhibition were observed, however, when ascorbic acid was omitted from the suspensions.
Effect of trivalent chromic cation on erythrocyte enzymes
The effect of trivalent chromic cation is shown in Figure 2 . There was essentially no effect on GSSG-R activity even when very large amounts (100 ,ug of Cr per ml of blood) were used. Also, the chromate effect was abolished when ascorbic acid was added to the suspension before incubation with chromate (Table II) 
Effect of chromate in hemolysates
Because of the observation that GSSG-R inhibition employing intact erythrocytes was associated only with chromium in the hexavalent form, studies were performed with hemolysates (prepared by freezing and thawinig) to determine whether the differences were due to inability of the trivalent chromium to enter the intact erythrocyte. Chromate produced a fall in GSSG-R activity of 407% with 10 ug of chromium per ml of original blood, 60%o with 25 Mug per ml, and 84%o when 100 Mg per ml of blood was added to the hemolysate followed by a 45-minute incubation.
In contrast, only 3%0 inhibition was observed when trivalent chromium ( 100 Mug chromium per ml of blood, final concentration 2 X 10-s M) was used.
Hexavalent but not trivalent chromium caused reduction of GSSG-R activity in hemolysates.
This difference was observed in the presence or absence of EDTA in the final assay system.
Effect of chromate-induced GSSG-R deficiency
Heinz body formation. Chromate-treated eryth- Glutathione stability. Incubation with 25 ug of sodium chromate per ml of original blood volume was associated with a modest decrease in erythrocyte GSH concentration (Table III) .
Some reduction in GSH concentration was generally noted on incubation with lesser amounts of chromate as well, but the results were inconsistent. Washing and resuspension of the erythrocytes in heparinized plasma were also irregularly associated with some decrease in erythrocyte GSH. When acetylphenylhydrazine was added to the incubation system, however, a definite further decrease in GSH concentration was observed (Table IV) . Similar results were obtained when GSH stability was followed in a glucose-containing phosphate buffer. The control samples incubated for 2 hours without acetylphenylhydrazine show what are perhaps significant differences in the degree of change in the GSH concentration in the samples exposed to 0 and The mechanisms of cell damage in spontaneous and chromate-induced GSSG-R deficiencies are not clear. It is unlikely that a resultant GSH de-ficiency alone can cause major shortening of erythrocyte survival since almost complete selective inhibition of intracellular erythrocyte GSH with N-ethylmaleimide does not seriously impair erythrocyte survival (24) . Also, a hereditary absence of GSH is associated with only a mild hemolytic state (25) .
Erythrocyte GSH concentration was decreased in the three cases (23, 24) cited above. Only a modest decrease in GSH was noted in chromateinduced GSSG-R deficiency. This may be due to the fact that GSH was measured only after short incubations in the absence of known oxidative stress. A rapid fall in GSH was noted after incubation with acetylphenyihydrazine. Because of the marked loss in activity of GSSG-R, this GSH instability was anticipated. GSH stability was not altered in the patient reported by Carson and co-workers (23) with a 43%o decrease in GSSG-R activity, but was abnormal in one of the patients reported by Lohr and Waller (22) with a more severe enzyme deficit.
The mechanism of Heinz body formation is possibly similar to that which occurs in G-6-P-D deficiency. Jandl (26) has recently suggested that Heinz body formation in congenital G-6-P-D and GSSG-R deficiencies is related to inability of these cells to protect hemoglobin by primary oxidation of cellular constituents with lower oxidation potentials such as glutathione.
Summary
The effect of sodium chromate on the activities of human erythrocyte enzymes was studied. There was no effect on the activities of the enzymes of the glycolytic pathway, on those of the pentosephosphate pathway which were studied, or of acetylcholinesterase and glyoxalase. Concentrations of chromate of 5 to 25 ttg of chromium per ml of blood produced major inhibition of erythrocyte glutathione reductase. The inhibition was induced by hexavalent chromate anion only, even in hemolysates. Trivalent chromic cation had no inhibitory effect. The inhibition was associated with increased sensitivity to acetylphenyllhydrazine manifested as Heinz body formation and GSH instability. No effect on osmotic fragility or on autohemolysis was observed.
